Global Information
회사소개 | 문의 | 비교리스트

세계의 소프트겔 캡슐 시장 : 예측

Global Softgel Capsule Market Research Report Forecast to 2023

리서치사 Market Research Future
발행일 2019년 04월 상품 코드 851701
페이지 정보 영문 95 Pages
가격
US $ 4,450 ₩ 5,288,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,427,000 Printable PDF (Corporate User License)


세계의 소프트겔 캡슐 시장 : 예측 Global Softgel Capsule Market Research Report Forecast to 2023
발행일 : 2019년 04월 페이지 정보 : 영문 95 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 소프트겔 캡슐(Softgel Capsule) 시장을 분석했으며, 제품 개요와 시장의 기본 구조, 주요 시장 성장 촉진요인 및 억제요인, 전체적인 시장 동향 전망(과거 및 향후 6년간), 타입별·용도별·지역별 상세 동향, 시장 점유율 구조, 주요 기업 개요·실적·전략 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 주요 요약

제3장 시장 개요

제4장 분석 방법

  • 서론
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 기술 동향과 평가
  • 거시경제 지표

제5장 시장 요인 분석

  • 밸류체인 분석
    • 연구개발(R&D), 설계
    • 제조
    • 유통 판매
    • 애프터서비스
  • Porter's Five Forces 분석
  • 투자 기회
  • 가격 동향 분석

제6장 세계의 소프트겔 캡슐 시장 : 타입별

  • 서론
    • 젤라틴 타입
    • 비동물계 타입
    • 젤라틴 캡슐
    • 비동물계 캡슐

제7장 세계의 소프트겔 캡슐 시장 : 용도별

  • 서론
    • 비타민
    • 서플리먼트
    • 영양분

제8장 세계의 소프트겔 캡슐 시장 : 지역별

  • 서론
  • 아메리카(북미, 라틴아메리카)
  • 유럽
  • 아시아태평양(중국, 일본 등)
  • 기타 국가(RoW)

제9장 경쟁 환경

  • 경쟁 시나리오
  • 기업별 시장 점유율 분석
  • 최근의 주요 동향

제10장 기업 개요

  • Catalent, Inc
  • Patheon(Thermo Fisher Scientific의 일부문)
  • Capsugel(Lonza의 일부문)
  • Captek Softgel International Inc.
  • EuroCaps Ltd.(DCC plc Group의 일부문)
  • Amway
  • Sirio Pharma Co. Ltd.
  • Strides Pharma Science Limited
  • International Vitamin Corporation
  • Soft Gel Technologies, Inc.
  • Weihai Baihe Biology Technological Co. Ltd.
  • China Shineway Pharmaceutical Group Limited
  • Yuwang Group
  • Guangdong Yichao Biological Co. Ltd.

제11장 부록

LSH 19.06.10

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 LIST OF ASSUMPTIONS
  • TABLE 3 GLOBAL SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 4 GLOBAL SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 5 GLOBAL SOFTGEL CAPSULE MARKET FOR GELATIN CAPSULE, BY REGION 2013-2023 (USD MILLION)
  • TABLE 6 GLOBAL SOFTGEL CAPSULE MARKET FOR GELATIN CAPSULE, BY REGION 2013-2023 (VOLUME MILLION)
  • TABLE 7 GLOBAL SOFTGEL CAPSULE MARKET FOR NON- ANIMAL CAPSULE, BY REGION 2013-2023 (USD MILLION)
  • TABLE 8 GLOBAL SOFTGEL CAPSULE MARKET FOR NON- ANIMAL CAPSULE, BY REGION 2013-2023 (VOLUME MILLION)
  • TABLE 9 GLOBAL SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 10 GLOBAL SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 11 GLOBAL SOFTGEL CAPSULE MARKET, FOR VITAMINS BY REGION, 2013-2023 (USD MILLION)
  • TABLE 12 GLOBAL SOFTGEL CAPSULE MARKET, FOR VITAMINS BY REGION, 2013-2023 (VOLUME MILLION)
  • TABLE 13 GLOBAL SOFTGEL CAPSULE MARKET, FOR SUPPLEMENT BY REGION, 2013-2023 (USD MILLION)
  • TABLE 14 GLOBAL SOFTGEL CAPSULE MARKET, FOR SUPPLEMENT BY REGION, 2013-2023 (VOLUME MILLION)
  • TABLE 15 GLOBAL SOFTGEL CAPSULE MARKET, FOR NUTRITION BY REGION, 2013-2023 (USD MILLION)
  • TABLE 16 GLOBAL SOFTGEL CAPSULE MARKET, FOR NUTRITION BY REGION, 2013-2023 (VOLUME MILLION)
  • TABLE 17 GLOBAL SOFTGEL CAPSULE MARKET, BY REGION 2013-2023 (USD MILLION)
  • TABLE 18 GLOBAL SOFTGEL CAPSULE MARKET, BY REGION 2013-2023 (VOLUME MILLION)
  • TABLE 19 AMERICAS SOFTGEL CAPSULE MARKET, BY REGION 2013-2023 (USD MILLION)
  • TABLE 20 AMERICAS SOFTGEL CAPSULE MARKET, BY REGION 2013-2023 (VOLUME MILLION)
  • TABLE 21 NORTH AMERICA SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 22 NORTH AMERICA SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 23 NORTH AMERICA SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 24 NORTH AMERICA SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 25 LATIN AMERICA SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 26 LATIN AMERICA SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 27 LATIN AMERICA SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 28 LATIN AMERICA SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 29 EUROPE SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 30 EUROPE SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 31 EUROPE SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 32 EUROPE SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 33 ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY COUNTRY 2013-2023 (USD MILLION)
  • TABLE 34 ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY COUNTRY 2013-2023 (VOLUME MILLION)
  • TABLE 35 CHINA SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 36 CHINA SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 37 CHINA SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 38 CHINA SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 39 JAPAN SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 40 JAPAN SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 41 JAPAN SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 42 JAPAN SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 43 REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 44 REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 45 REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 46 REST OF ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 47 REST OF THE WORLD SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (USD MILLION)
  • TABLE 48 REST OF THE WORLD SOFTGEL CAPSULE MARKET, BY TYPE 2013-2023 (VOLUME MILLION)
  • TABLE 49 REST OF THE WORLD SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (USD MILLION)
  • TABLE 50 REST OF THE WORLD SOFTGEL CAPSULE MARKET, BY APPLICATION 2013-2023 (VOLUME MILLION)
  • TABLE 51 GLOBAL SOFTGEL CAPSULE MARKET: KEY DEVELOPMENT

List of Figures

  • FIGURE 1 GLOBAL SOFTGEL CAPSULES MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS OF MRFR
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 VALUE CHAIN: GLOBAL SOFTGEL CAPSULE MARKET
  • FIGURE 5 PORTER'S FIVE FORCES MODEL: GLOBAL SOFTGEL CAPSULE MARKET
  • FIGURE 6 GLOBAL SOFTGEL CAPSULE MARKET, BY TYPE 2017 & 2023 (USD MILLION)
  • FIGURE 7 GLOBAL SOFTGEL CAPSULE MARKET, BY APPLICATION 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL SOFTGEL CAPSULE MARKET, BY REGION 2017 & 2023 (USD MILLION)
  • FIGURE 9 ASIA-PACIFIC SOFTGEL CAPSULE MARKET, BY COUNTRY 2017 & 2023 (USD MILLION)
  • FIGURE 10 GLOBAL SOFTGEL CAPSULE MARKET COMPETITIVE LANDSCAPE (%)
  • FIGURE 11 GLOBAL SOFTGEL CAPSULE MARKET, MARKET SHARE ANALYSIS 2017 (%)

Introduction

A softgel capsule is a solid capsule which contains a liquid or semi-solid active ingredient into it. Soft gelatin capsules are generally used in the medical industry as a container for drugs. These capsules can accommodate a wide range of pharmaceutical compounds filled as a semi-solid, liquid, gel, or paste. The rising demand for nutraceuticals, increasing investments in capsule manufacturing plants, and rising applications of softgel capsules in nutraceutical industries are expected to increase the growth of the market during the forecast period. However, the high cost of vegetarian capsules, fluctuating prices of raw materials, and rising demand for kosher- and halal-certified hard gelatin capsules are estimated to lag the market growth during the forecast period.

The global softgel capsule market is expected to reach a market value of USD 3,276 million by 2023 from USD 2,381.90 million in 2017 and is expected to register a CAGR of 5.46% during the forecast period from 2018 to 2023. In 2017, the market was led by North America at a 31.4% share, followed by Europe and China with shares of 29.7% and 6.0%, respectively.

The global softgel capsule market is segmented into type, application, and region.

The global softgel capsule market, by type, is segmented into gelatin type and non-animal type.

The global softgel capsule market, by application, is segmented into vitamins, supplement, nutrition, and others.

Key Players

Catalent, Inc, Patheon (Part of Thermo Fisher Scientific), Capsugel (A part of Lonza), Captek Softgel International Inc., EuroCaps Ltd, Amway, Sirio Pharma Co. Ltd., Strides Pharma Science Limited, International Vitamin Corporation, Weihai Baihe Biology Technological Co. Ltd., China Shineway Pharmaceutical Group Limited, Yuwang Group, Guangdong Yichao Biological Co. Ltd., and Soft Gel Technologies, Inc.

Study Objectives

  • To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the softgel capsule market
  • To provide insights into factors affecting the market growth
  • To analyze the global softgel capsule market based on various tools such as supply chain analysis and Porter's five force analysis
  • To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
  • To provide country-level analysis of the market with respect to the current market size and future perspective
  • To provide country-level analysis of the market for segments by type, application, and region
  • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the softgel capsule market

Target Audience

  • Soft Gel Capsules Manufacturers
  • Soft Gel Capsules Suppliers
  • Medical Research Laboratories
  • Research Institutes
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors

Key Findings

  • The global softgel capsule market is expected to reach USD 3,276 million by 2023 at a CAGR of 5.46% from 2018 to 2023
  • On the basis of type, the gelatin type segment is expected to account for the largest market share at a CAGR of 5.31% by 2023
  • On the basis of application, the vitamins segment is expected to account for the largest market share at a CAGR of 4.86% by 2023
  • North America is expected to hold the largest share of the global softgel capsule market at a CAGR of 6.20% by 2023
  • The rest of Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 5.71% by 2023

Regional Analysis

  • Americas
    • North America
    • Latin America
  • Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia-Pacific
  • Rest of the World

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Scope of Study
  • 2.2 Research Objective
  • 2.3 List of Assumptions
  • 2.4 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Increasing investments by major market players in capsule manufacturing plants
    • 4.2.2 Rising applications of softgel capsules in nutraceutical industries
    • 4.2.3 Growth of the pharmaceutical industry provides opportunities for the softgel capsules market to grow worldwide
  • 4.3 Restraints
    • 4.3.1 High cost of vegetarian capsules
    • 4.3.2 Fluctuating prices of raw materials
    • 4.3.3 Rising demand for kosher- and halal-certified hard gelatin capsules
  • 4.4 Opportunities
    • 4.4.1 Non-gelatin softgel capsules
  • 4.5 Technology Trends & Assessment
    • 4.5.1 'Smart capsule' is a potential new drug-delivery vehicle
    • 4.5.2 Hydroxypropyl methylcellulose capsules (HPMC)
  • 4.6 Macroeconomic indicators

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Post-sales Review
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Investment Opportunities
  • 5.4 Pricing Analysis

6 Global Softgel Capsule Market, By Type

  • 6.1 Introduction
    • 6.1.1 Gelatin type
    • 6.1.2 Non-animal type
    • 6.1.3 Gelatin Capsule
    • 6.1.4 Non- animal Capsule

7 Global Softgel Capsule Market, By Application

  • 7.1 Introduction
    • 7.1.1 Vitamins
    • 7.1.2 Supplement
    • 7.1.3 Nutrition
    • 7.1.4 Vitamins
    • 7.1.5 Supplement
    • 7.1.6 Nutrition

8 Global Softgel Capsule Market, By Region

  • 8.1 Introduction
  • 8.2 Americas
    • 8.2.1 North America
    • 8.2.2 Latin America
  • 8.3 Europe
  • 8.4 Asia - Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 Rest of Asia-Pacific
  • 8.5 Rest of the World

9 Competitive Landscape

  • 9.1 Competitive Scenario
    • 9.1.1 Introduction
  • 9.2 Company Market Share Analysis
    • 9.2.1 Introduction
  • 9.3 Key Developments

10 Company Profile

  • 10.1 Catalent, Inc
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Products Offering
    • 10.1.4 SWOT Analysis
    • 10.1.5 Key Developments
    • 10.1.6 Key strategy
  • 10.2 Patheon (Part of Thermo Fisher Scientific)
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Products Offering
    • 10.2.4 SWOT Analysis
    • 10.2.5 Key Developments
    • 10.2.6 Key strategy
  • 10.3 Capsugel (A part of Lonza)
    • 10.3.1 Company Overview
    • 10.3.2 Company Overview
    • 10.3.3 Products Offering
    • 10.3.4 SWOT Analysis
    • 10.3.5 Key Developments
    • 10.3.6 Key strategy
  • 10.4 Captek Softgel International Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Products Offering
    • 10.4.4 SWOT Analysis
    • 10.4.5 Key Developments
    • 10.4.6 Key Strategy
  • 10.5 EuroCaps Ltd. (Part of the DCC plc Group)
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Products Offering
    • 10.5.4 SWOT Analysis
    • 10.5.5 Key Developments
    • 10.5.6 Key Strategy
  • 10.6 Amway
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Products Offering
    • 10.6.4 SWOT Analysis
    • 10.6.5 Key Development
    • 10.6.6 Key Strategy
  • 10.7 Sirio Pharma Co. Ltd.
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Products Offering
    • 10.7.4 SWOT Analysis
    • 10.7.5 Key Development
    • 10.7.6 Key Strategy
  • 10.8 Strides Pharma Science Limited
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Products Offering
    • 10.8.4 SWOT Analysis
    • 10.8.5 Key Development
    • 10.8.6 Key Strategy
  • 10.9 International Vitamin Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Products Offering
    • 10.9.4 SWOT Analysis
    • 10.9.5 Key Development
    • 10.9.6 Key Strategy
  • 10.1 Soft Gel Technologies, Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Products Offering
    • 10.10.3 SWOT Analysis
    • 10.10.4 Key Development
    • 10.10.5 Key Strategy
  • 10.11 Weihai Baihe Biology Technological Co. Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Financial Overview
    • 10.11.3 Products Offering
    • 10.11.4 SWOT Analysis
    • 10.11.5 Key Development
    • 10.11.6 Key Strategy
  • 10.12 China Shineway Pharmaceutical Group Limited
    • 10.12.1 Company Overview
    • 10.12.2 Financial Overview
    • 10.12.3 Products Offering
    • 10.12.4 SWOT Analysis
    • 10.12.5 Key Development
    • 10.12.6 Key Strategy
  • 10.13 Yuwang Group
    • 10.13.1 Company Overview
    • 10.13.2 Financial Overview
    • 10.13.3 Products Offering
    • 10.13.4 SWOT Analysis
    • 10.13.5 Key Development
    • 10.13.6 Key Strategy
  • 10.14 Guangdong Yichao Biological Co. Ltd.
    • 10.14.1 Company Overview
    • 10.14.2 Financial Overview
    • 10.14.3 Products Offering
    • 10.14.4 SWOT Analysis
    • 10.14.5 Key Development
    • 10.14.6 Key Strategy

11 Appendix

  • 11.1 Discussion Blue Print
Back to Top
전화 문의
F A Q